Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7568282 in Early Symptomatic Alzheimer's Disease
NCT07781657Phase 2Not yet recruiting
- Sponsor
- Roche
- Start
- Oct 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of RO7568282 in Alzheimer's disease (AD), sponsored by Roche. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
RO7568282
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07781657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781657.